Advestra advised Sandoz, a generic and biosimilar medicines specialist with headquarters in Basel, on its CHF 550 million bonds issuance. The issuance comprises a CHF 275 million tranche with a six-year maturity and a 1.1875% coupon, and a
Tags :Sandoz
Sandoz, a global leader in the generics and biosimilars markets successfully placed EUR 600 million senior guaranteed Eurobonds listed on the SIX Swiss Exchange, advised by Advestra. The bonds are issued by Sandoz Finance B.V.
